Stock MET.PRE METLIFE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings MetLife, Inc. Nyse

Equities

MET.PRE

US59156R8768

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-31 EDT 		5-day change 1st Jan Change
23.75 USD +0.30% Intraday chart for MetLife, Inc. -0.21% -2.22%
05-31 Sector Update: Financial Stocks Rise Late Afternoon MT
05-31 Sector Update: Financial MT

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • One of the major weak points of the company is its financial situation.

Ratings chart - Surperformance

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
METLIFE, INC. Stock MetLife, Inc.
-2.22% 51.46B -
AXA Stock AXA
+12.07% 78.88B
B-
AFLAC INCORPORATED Stock Aflac Incorporated
+8.93% 51.07B
B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+20.90% 46.59B
B+
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+16.04% 43.21B
B+
GENERALI Stock Generali
+23.53% 39.69B
B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
-0.60% 29.1B
B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-6.79% 27.94B
B-
PRUDENTIAL PLC Stock Prudential plc
-15.80% 26.05B
A-
CATHAY FINANCIAL HOLDING CO., LTD. Stock Cathay Financial Holding Co., Ltd.
+22.84% 25.35B
A
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. MET Stock
  4. MET.PRE Stock
  5. Ratings MetLife, Inc.